All treatments
Treatment
BNT327 Dose Level 1 (DL1) clinical trials
2 indexed studies · 0 currently recruiting
- Active not recruitingPHASE2
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
This study is testing a new drug, BNT327, for advanced breast cancer (called triple-negative). Researchers want to see if it's safe and works well when given with chemotherapy. It's for people whose cancer has spread or is difficult to treat.
For: Locally Advanced Breast Cancer · Triple Negative Breast Cancer · Metastatic Triple Negative Breast CancersUnited States · Australia · Turkey (Türkiye) - Active not recruitingPHASE2
Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy
This study is looking at a new treatment called BNT327 for tiny-cell lung cancer. It combines BNT327 with chemotherapy to see how safe and effective it is for people whose cancer is widespread or has come back after other treatments.
For: Extensive-stage Small-cell Lung Cancer · Small-cell Lung CancerUnited States · Australia · South Korea